Download
|
< Back |
| 29 Oct 2025 | |
| Pursuant to Regulation 30 of SEBI (LODR) 2015, we wish to inform you that company has scheduled a conference call with analysts/Investor on 04, November, 2025 to discuss its Q2 FY 26 Financial Results. | |
| View all announcements for Jagsonpal Pharmaceuticals Ltd | Source: BSE India |